APA (7th ed.) Citation

EH, L., MH, K., DH, K., J, M., SH, K., JS, E., . . . J, C. (2026). Clinical impact of local consolidative therapy in EGFR-mutant metastatic NSCLC: A propensity-matched multicenter analysis. Lung cancer (Amsterdam, Netherlands), 217, 109423. https://doi.org/10.1016/j.lungcan.2026.109423

Chicago Style (17th ed.) Citation

EH, Lee, et al. "Clinical Impact of Local Consolidative Therapy in EGFR-mutant Metastatic NSCLC: A Propensity-matched Multicenter Analysis." Lung Cancer (Amsterdam, Netherlands) 217 (2026): 109423. https://doi.org/10.1016/j.lungcan.2026.109423.

MLA (9th ed.) Citation

EH, Lee, et al. "Clinical Impact of Local Consolidative Therapy in EGFR-mutant Metastatic NSCLC: A Propensity-matched Multicenter Analysis." Lung Cancer (Amsterdam, Netherlands), vol. 217, 2026, p. 109423, https://doi.org/10.1016/j.lungcan.2026.109423.